Skip to main content

Antiplatelet agents

What are Antiplatelet agents?

Antiplatelet agents are medicines that reduce the ability of platelets to stick together (called platelet aggregation) and inhibit the formation of blood clots.

Antiplatelet agents play a major role in the treatment and prevention of myocardial infarction (heart attacks), stent thrombosis, and ischemic stroke (strokes caused by a blood clot).

Antiplatelet agents can be divided into three major types:

  • glycoprotein platelet inhibitors (eg, abciximab, eptifibatide, tirofiban)
  • platelet aggregation inhibitors (eg, aspirin, cangrelor, cilostazol, clopidogrel, dipyridamole, prasugrel, ticlopidine, ticagrelor)
  • protease-activated receptor-1 antagonists (eg, vorapaxar).

Types of Antiplatelet agents

Please refer to the drug classes listed below for further information.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.